CIK 0001798749
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Jade Biosciences, Inc.
Sign in to watch- Ticker
- JBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831377888
- Phone
- +1 781-312-3013
- Business address
- 221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- Aerovate Therapeutics, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Other acquisition 10% owner acquired 1,062,326 shares (other)
- 4 Exercise or conversion Dake Benjamin T acquired 12,961 shares (option exercise)
- 4 Open-market buy Director bought 928,110 shares at $1.67 ($1,549,944)
- 4 Planned sale Eldridge George A sold 15,000 shares at $25.03 ($375,450)
- 4 Planned sale CHIEF TECHNICAL OFFICER sold 10,600 shares at $25.00 ($265,000)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 6,000 shares at $24.50 ($147,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 11 · 214 filings